MAQTOX and Telomir Pharmaceuticals Present Groundbreaking Data on Telomir-1 for Age-Related Chronic
MAQTOX, in collaboration with Telomir Pharmaceuticals, has made significant strides in the fight against age-related diseases through their groundbreaking research on Telomir-1. This novel therapeutic compound has shown promising results in the extension of telomeres
